NO20073550L - Hydantoinderivater nyttige som metallproteinaseinhibitorer - Google Patents

Hydantoinderivater nyttige som metallproteinaseinhibitorer

Info

Publication number
NO20073550L
NO20073550L NO20073550A NO20073550A NO20073550L NO 20073550 L NO20073550 L NO 20073550L NO 20073550 A NO20073550 A NO 20073550A NO 20073550 A NO20073550 A NO 20073550A NO 20073550 L NO20073550 L NO 20073550L
Authority
NO
Norway
Prior art keywords
derivatives useful
proteinase inhibitors
hydantoin derivatives
metal proteinase
metal
Prior art date
Application number
NO20073550A
Other languages
English (en)
Norwegian (no)
Inventor
David Waterson
David Jonas Persson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20073550L publication Critical patent/NO20073550L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20073550A 2004-12-15 2007-07-09 Hydantoinderivater nyttige som metallproteinaseinhibitorer NO20073550L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427403.1A GB0427403D0 (en) 2004-12-15 2004-12-15 Novel compounds I
PCT/GB2005/004811 WO2006064218A1 (en) 2004-12-15 2005-12-14 Hydantoin derivatives useful as metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
NO20073550L true NO20073550L (no) 2007-09-11

Family

ID=34090044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073550A NO20073550L (no) 2004-12-15 2007-07-09 Hydantoinderivater nyttige som metallproteinaseinhibitorer

Country Status (30)

Country Link
US (1) US8129412B2 (es)
EP (1) EP1828166B1 (es)
JP (1) JP5042849B2 (es)
KR (1) KR20070090921A (es)
CN (1) CN101080402B (es)
AR (1) AR051797A1 (es)
AU (1) AU2005315459B2 (es)
BR (1) BRPI0519057A2 (es)
CA (1) CA2589525A1 (es)
CY (1) CY1109376T1 (es)
DE (1) DE602005015617D1 (es)
DK (1) DK1828166T3 (es)
ES (1) ES2328836T3 (es)
GB (1) GB0427403D0 (es)
HK (1) HK1108435A1 (es)
HR (1) HRP20090489T1 (es)
IL (1) IL183590A0 (es)
MX (1) MX2007006744A (es)
NO (1) NO20073550L (es)
NZ (1) NZ555684A (es)
PL (1) PL1828166T3 (es)
PT (1) PT1828166E (es)
RS (1) RS51193B (es)
RU (1) RU2388758C2 (es)
SA (1) SA05260406B1 (es)
SI (1) SI1828166T1 (es)
TW (1) TW200634001A (es)
UA (1) UA89067C2 (es)
WO (1) WO2006064218A1 (es)
ZA (1) ZA200705068B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2705414C (en) 2007-10-19 2016-05-24 Boehringer Ingelheim International Gmbh Substituted piperidino-dihydrothienopyrimidines
WO2009138777A1 (en) * 2008-05-12 2009-11-19 Astrazeneca Ab Process for the preparation of alkoxy-phenoxy-pi peridine
US7759512B2 (en) 2008-07-21 2010-07-20 3M Innovative Properties Company Aqueous methods for making fluorinated sulfonate esters
CN102234287B (zh) 2010-04-26 2015-08-05 上海阳帆医药科技有限公司 硝基咪唑类化合物、其制备方法和用途
US8895737B2 (en) 2010-07-16 2014-11-25 Shashank Shekhar Process for preparing antiviral compounds
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
NZ704603A (en) 2010-07-16 2016-06-24 Abbvie Inc Phosphine ligands for catalytic reactions
HUP1300139A2 (en) 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists
US20160364553A1 (en) * 2015-06-09 2016-12-15 Intel Corporation System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network
GB201610056D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919776D0 (en) 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
JP2003501414A (ja) 1999-06-04 2003-01-14 アストラゼネカ・アクチエボラーグ メタロプロテイナーゼの阻害剤
UA73155C2 (en) 2000-02-21 2005-06-15 Astrazeneca Ab Substituted by piperidine and piperazine n-hydroxyformamides as metalloproteinase inhibitors
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0301922D0 (sv) 2003-06-27 2003-06-27 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
WO2006064218A1 (en) 2006-06-22
SA05260406B1 (ar) 2009-02-02
UA89067C2 (ru) 2009-12-25
EP1828166B1 (en) 2009-07-22
AR051797A1 (es) 2007-02-07
NZ555684A (en) 2009-11-27
DE602005015617D1 (de) 2009-09-03
IL183590A0 (en) 2007-09-20
CY1109376T1 (el) 2014-07-02
ES2328836T3 (es) 2009-11-18
JP2008524184A (ja) 2008-07-10
DK1828166T3 (da) 2009-10-05
ZA200705068B (en) 2008-10-29
PT1828166E (pt) 2009-09-16
CN101080402B (zh) 2010-12-08
US20080280950A1 (en) 2008-11-13
RU2388758C2 (ru) 2010-05-10
HK1108435A1 (en) 2008-05-09
SI1828166T1 (sl) 2009-12-31
EP1828166A1 (en) 2007-09-05
CA2589525A1 (en) 2006-06-22
RS51193B (sr) 2010-10-31
TW200634001A (en) 2006-10-01
BRPI0519057A2 (pt) 2008-12-23
MX2007006744A (es) 2007-07-09
RU2007121222A (ru) 2009-01-27
JP5042849B2 (ja) 2012-10-03
KR20070090921A (ko) 2007-09-06
AU2005315459A1 (en) 2006-06-22
HRP20090489T1 (hr) 2009-10-31
CN101080402A (zh) 2007-11-28
AU2005315459B2 (en) 2009-01-08
US8129412B2 (en) 2012-03-06
PL1828166T3 (pl) 2009-12-31
GB0427403D0 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
NO20073550L (no) Hydantoinderivater nyttige som metallproteinaseinhibitorer
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20076450L (no) Heterosykliske forbindelser som nikotinsyrereseptoragonister for behandling av dyslipidemi
NO20063928L (no) Substituerte kinolinforbindelser
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
NO20091560L (no) Biaryleterureaforbindelser
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20071594L (no) Pyrimidinsulfonamidderivater som kjemokinreseptormodulatorer
NO20050016L (no) Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen
NO20051263L (no) Ny anvendelse av benzotiazolderivater
NO20073101L (no) Nye pyridinforbindelser
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
TW200732336A (en) Alyphactic heterocyclic compounds
NO20090327L (no) Nye forbindelser 384
NO20064951L (no) 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
NO20076682L (no) Nye pyridinanaloger
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
NO20082054L (no) Nye 2-fenylimidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase for behandling av demens og neurodegenerative forstyrrelser
NO20044571L (no) Isokinolinderivater
NO20081216L (no) Amidderivater
WO2003074513A3 (en) Indole amide derivatives and their use as glycogen phosphorylase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application